{"id":"https://openalex.org/W47831966","doi":null,"title":"Abstract 1928: Effects of a Selective Inhibitor of Secretory Phospholipase A2 on Low Density and Very Low Density Lipoprotein Subclasses in Stable Coronary Heart Disease Patients","display_name":"Abstract 1928: Effects of a Selective Inhibitor of Secretory Phospholipase A2 on Low Density and Very Low Density Lipoprotein Subclasses in Stable Coronary Heart Disease Patients","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-28","ids":{"openalex":"https://openalex.org/W47831966","mag":"47831966"},"language":"en","primary_location":{"id":"mag:47831966","doi":null,"is_oa":false,"landing_page_url":"http://circ.ahajournals.org/cgi/content/meeting_abstract/118/18_MeetingAbstracts/S_406-d","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W47831966"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060465607","display_name":"Robert S. Rosenson","orcid":"https://orcid.org/0000-0002-5599-0633","observed_orcids":["https://orcid.org/0000-0002-5599-0633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert S. Rosenson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5599-0633","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006919099","display_name":"Colin Hislop","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Hislop","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020637231","display_name":"Michael D. Elliott","orcid":"https://orcid.org/0000-0002-9057-3915","observed_orcids":["https://orcid.org/0000-0002-9057-3915"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Elliott","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9057-3915","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056005655","display_name":"Yuri Stasiv","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuri Stasiv","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"118","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.17219999432563782,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secretory-phospholipase-a2","display_name":"secretory phospholipase A2","score":0.9810000061988831},{"id":"https://openalex.org/keywords/spla2-inhibitors","display_name":"sPLA2 inhibitors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/stable-coronary-artery-disease","display_name":"stable coronary artery disease","score":0.8920000195503235},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/lipoprotein-modification","display_name":"lipoprotein modification","score":0.8949999809265137},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8966224193572998},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.673188328742981},{"id":"https://openalex.org/C2777034527","wikidata":"https://www.wikidata.org/wiki/Q18032676","display_name":"Lipoprotein-associated phospholipase A2","level":4,"score":0.60914546251297},{"id":"https://openalex.org/C2776551241","wikidata":"https://www.wikidata.org/wiki/Q24768001","display_name":"Phospholipase A2","level":3,"score":0.5173584818840027},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4772112965583801},{"id":"https://openalex.org/C2779620165","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Low-density lipoprotein","level":3,"score":0.47574281692504883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4745030105113983},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.45796823501586914},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4042423665523529},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.3984617590904236},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37618550658226013},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.23406982421875},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1634783148765564},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.15015605092048645},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:47831966","doi":null,"is_oa":false,"landing_page_url":"http://circ.ahajournals.org/cgi/content/meeting_abstract/118/18_MeetingAbstracts/S_406-d","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1580461158","https://openalex.org/W2004855716","https://openalex.org/W2078624782","https://openalex.org/W76650249","https://openalex.org/W2066052207","https://openalex.org/W2039640108","https://openalex.org/W2032374475","https://openalex.org/W2094576687","https://openalex.org/W2182439912","https://openalex.org/W2033247700"],"abstract_inverted_index":{"Secretory":[0],"phospholipase":[1],"A2":[2],"(sPLA2)":[3],"represents":[4],"a":[5],"family":[6],"of":[7,15,22],"pro-inflammatory":[8],"enzymes":[9],"that":[10,24],"contribute":[11],"to":[12],"the":[13],"development":[14],"atherosclerosis":[16],"in":[17],"part":[18],"through":[19],"adverse":[20],"modification":[21],"lipoproteins":[23],"re...":[25]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W47831966","counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}
